KRAS and lung cancer: Also, 1,25(OH)2D inhibits signaling pathways that promote lung cancer including mutations in K-Ras and epidermal growth factor receptor (EGFR), dysregulation of Wnt/β-catenin, which determines metastasis and proliferation [5, 45, 46].